Maintaining Progressive at Outperform: An 86.4 Combined Ratio and a Run at #1 US Auto for ~10x Earnings — Our Call Has Lagged, But the De-Rating Has Made the Thesis Cheaper, Not Broken

Results vs. Consensus

Q1 2026 Scorecard

Year-Over-Year Comparison (Q1 2026 vs. Q1 2025)

Sequential Comparison (Q1 2026 vs. Q4 2025)

Quality of the Quarter

The deceleration is real — and it is the story. Revenue grew 8.7% and EPS 9.8%, both down sharply from FY2025's +16% / +33%. This is exactly the lapping-of-records dynamic management has flagged for a year, now arriving in the numbers. It is not deterioration: ~1 million policies were added in the quarter, the combined ratio held at 86.4, and Progressive still captured the lion's share of industry growth. But the era of 30%+ earnings growth is over, and the market is repricing accordingly.

Loss costs cooperated. Severity of ~3% with flat frequency is a benign cost backdrop, and collision severity is among the best in five years. The watch items — bodily-injury severity (attorney representation, large losses) and parts-price inflation — are present but offset by claims-handling efficiency and a lower mix of high-speed highway accidents. Nothing in the loss data threatens the sub-90 combined ratio.

Capital efficiency keeps improving. Equity rose 5.7% sequentially (recovering from the Q4 variable-dividend paydown), the 3.5:1 premiums-to-surplus migration continues to lift ROE structurally, and management raised opportunistic corporate debt (financial leverage back above 20%, still well under the 30% cap) while continuing to repurchase shares scaled to the discount to fair value. The capital story remains a clear positive.

Segment Performance

Personal Auto — The Run at #1

Personal auto added ~1 million PIFs in Q1 and pushed market share to 18.6%, putting the #1 US personal-auto crown within reach. The share-gain pace is historically singular — two consecutive years of >1.5-point gains, unmatched by any top-20 carrier since at least 1996. Written premium per policy ran ~ -1% as Progressive deliberately trimmed new-business rates in select states to capture in-market shoppers and as the mix shifted with a more open underwriting aperture. Conversion is up year-to-date, and management spent a record amount on media (+20% YoY) because the marginal spend still clears its cost-per-sale target.

"As we close in on the important milestone of becoming the number one writer of U.S. personal auto, we're not taking our foot off the gas." — Pat Callahan, President, Personal Lines

Assessment: The engine is firing and the share trajectory is exceptional. The slightly negative premium-per-policy is a deliberate growth-and-affordability choice, not pricing weakness. The decelerating premium growth rate is the law of large numbers plus selective rate cuts — policy growth, the metric management cares about, remains strong.

Property — Re-Opening, Carefully

Property is "slowly starting to increase [the] appetite for property growth on our own paper," building on two years of exceptional profitability and de-risking. The aim is to capture more of the high-value bundled "Robinson" segment.

Assessment: The property pivot from liability to growth asset is proceeding on schedule and underwrites the multi-year bundling thesis. Measured and on track; positive.

Commercial Lines — Profitable in an Unprofitable Industry

Commercial auto remained excellent against an industry that, per preliminary results, again posted an underwriting loss amid nuclear verdicts and social inflation. Progressive is increasing commercial media spend, cutting rates in select states/segments at or below profit targets, and rolling out next-generation product models across core commercial auto, medium fleet, and small business.

Assessment: A differentiated, durably profitable franchise. Trucking remains a deliberate drag; the BOP/medium-fleet expansion plus next-gen models are the growth levers. Neutral-to-positive.

Key Operating & Capital KPIs

Key Topics & Management Commentary

Overall Management Tone: Confident but measured, with a notable emphasis on perspective — the prepared remarks opened by asking investors not to "take for granted" performance that has been this strong for this long. Management leaned into the run at #1 US auto and the singular share-gain record, while candidly acknowledging the market is now "competitive, as it has been for the last 5+ quarters," that growth comparisons are hard, and that macro risks (fuel prices, the Iran conflict, tariffs) bear watching. On capital and AI the team was forthcoming and consistent with the Q4 deep-dive. The posture was of a franchise compounding through a softening market, comfortable that the flywheel keeps turning even as the year-over-year growth optics cool.

1. The Run at #1 US Personal Auto

The quarter's defining theme is proximity to the #1 US personal-auto crown. Progressive reached 18.6% share after gaining 1.9 points in 2025, a feat management framed as historically unmatched.

"In personal auto, we gained 1.9 points of market share in 2025, moving us up to 18.6% share, our second straight year gaining more than 1.5 points, which no other top 20 company has done going back to at least 1996... it took 84 years to get to 15.2 points of U.S. auto market share and only 2 years to add another 23% more on top of that." — Pat Callahan, President, Personal Lines

Assessment: The share-gain record is the clearest proof of a durable competitive advantage, and reaching #1 would be a milestone that reframes Progressive's scale narrative. The market, fixated on the decelerating growth rate, is under-weighting the absolute dominance of the franchise. This is the heart of the Outperform case.

2. The Soft, Competitive Market — and Why Progressive Wins In It

With the whole industry enjoying strong margins, competition has intensified and a soft market has set in. Management neither fought the characterization nor expressed concern, framing competition as good for consumers and a setting Progressive thrives in.

"We don't know how long the soft market will prevail, but we have definitely seen a lot more competition because everyone has great margins... In 2025, the private passenger auto market grew written premium about $11.8 billion. $8.9 billion of that was us... If you take just the top 10 carriers, that combined growth in 2025 was $10.4 billion. So we were 86% of that growth." — Tricia Griffith, CEO & President

Assessment: The most important framing on the call. Even in a soft, competitive market, Progressive captured the overwhelming majority of industry growth — evidence that its data/pricing/expense flywheel widens its lead precisely when conditions normalize. The bear worry that competition caps Progressive is contradicted by Progressive taking ~75–86% of the industry's growth.

3. Benign Loss Trends — Severity ~3%, Frequency Flat

Loss costs cooperated: severity ~3% overall, frequency roughly flat, and collision severity among the best in five years. Bodily-injury severity (attorney representation, large losses) and parts-price inflation are the watch items, partly offset by claims-handling efficiency.

"We see frequency moderating a little bit... in this quarter we are more flat for frequency... On the severity side, you mentioned BI. Yes, large losses and attorney-rep mix have impacted BI severity. For PD and collision, we do see higher parts prices... but we've been able to find ways to offset severity increases." — Andrew Quigg, Chief Strategy Officer (incoming CFO)

Assessment: A benign cost backdrop underwrites continued sub-90 combined ratios and gives Progressive room to keep cutting price to grow. The BI/parts watch items are real but managed. Supportive of margins and of the rate-cut-to-grow strategy.

4. The GenAI Expense Lever

Management has multiple generative-AI solutions in production that it believes deliver "meaningful, long-term" productivity, with internal estimates pointing to ~10% more output at the same headcount, and expects to keep reducing the non-acquisition expense ratio across its new three-year plan.

"We do have several generative AI solutions in production and we believe they're delivering meaningful benefits that we think will be long-term... we believe that we can continue to reduce non-acquisition expense ratio over the foreseeable future." — Tricia Griffith, CEO & President

Assessment: Expense-ratio leadership is one of Progressive's quiet, compounding moats; GenAI extends it. Every basis point of expense savings becomes either a lower price (widening the relative advantage) or margin. Hard to quantify, but a credible structural tailwind given Progressive's innovation track record.

5. Capital — Buybacks Scaled to Discount, Plus an Opportunistic Debt Raise

The capital framework from the Q4 deep-dive is executing: reinvest in growth first, then scale buybacks to the discount-to-fair-value, then corporate development / investment risk, then the variable dividend. Q1 saw "a fair amount" of buybacks and a corporate debt raise that lifted financial leverage back above 20% (from below) toward a more efficient level.

"We specifically look at... price-to-earnings, price-to-book, and then we have our own internal model... and we look to scale the share repurchase plan... based on how much of a discount we see that the shares are trading versus what our view of fair value is." — Jonathan Bauer, Chief Investment Officer

Assessment: Management has explicitly tied buyback intensity to the discount to fair value — so a stock trading at ~10x earnings should, by its own framework, draw more repurchases. That is a self-reinforcing support at these levels and a direct corroboration of our valuation case. The debt raise at sub-20% leverage is sensible balance-sheet optimization.

6. Premiums-to-Surplus — The Structural ROE March Continues

Management reiterated the multi-year plan to optimize premiums-to-surplus toward the approved 3.5:1 at most subsidiaries, which lowers the GAAP equity required and lifts ROE. The migration is incomplete — capital could not all be moved in 2025 — leaving a runway into 2026–2027.

"We received approval to go to 3.5:1 in by far the majority of our operating entities... Our aspiration is to continue to move premium-to-surplus ratios up... which obviously allows us to decrease the total equity we require on a GAAP basis, which obviously then can lead to higher ROEs." — John Sauerland, CFO

Assessment: An underappreciated, multi-year structural positive that directly counters the "ROE normalizes lower" bear case — the leverage migration is a tailwind to ROE that partially offsets cyclical normalization. The market is not crediting it.

7. Macro Watch — Fuel, Iran, Tariffs

Management flagged a more uncertain macro backdrop: higher fuel prices (ambiguous net effect on frequency and severity), the Iran conflict, and tariffs — all monitored and fed into pricing as appropriate, with near-record margins providing absorption capacity.

"While the macro environment could put upward pressure on pricing in the future, today we're still delivering near-record personal auto margins and focused on growing as quickly as possible." — Pat Callahan, President, Personal Lines

Assessment: The macro list is longer than a year ago, but Progressive's pricing speed and margin cushion make it the best-positioned carrier to absorb and re-price any shock. A risk to monitor, not a thesis-changer.

8. Unprecedented Shopping — A Tailwind for the Value Leader

Management described "unprecedented" consumer shopping — including long-tenured customers who hadn't shopped in a decade re-entering the market as affordability bites — and framed it as a structural advantage for the lowest-cost, best-segmented carrier.

"We've seen kind of unprecedented shopping and we don't expect to see it slow down... We think we win when more people shop and find that Progressive offers a competitive price for the value or coverage they're seeking." — Pat Callahan, President, Personal Lines

Assessment: Elevated shopping is a double-edged sword (it pressures retention/PLE) but net-favorable for Progressive: as the value leader with the best rate-to-risk matching, more shopping means more chances to win profitable policies. It is why the record media spend is rational.

Guidance & Outlook

No formal guidance, per Progressive's standard. The operating frame entering the rest of 2026:

Implied trajectory: High-single-digit revenue and EPS growth (moderating from the FY2025 surge), a combined ratio in the mid-80s, a structurally rising ROE from the leverage migration and GenAI expense leverage, and ongoing capital return. The growth deceleration is the consensus story; the under-appreciated offsets are the leverage/expense ROE tailwinds and the sheer share-gain dominance.

Analyst Q&A Highlights

How Long Does the Soft Market Last — and Where Does It Leave Progressive?

The opening line of questioning pressed on the trajectory of the soft, competitive personal-auto market and whether profitability could decline into 2027. Management declined to forecast the industry but reframed the question around Progressive's disproportionate share of growth.

Q: "Are we in a prolonged soft market just given the profitability environment? ... should we think about the industry being more competitive and profitability declining in 2027? Can you help us think about the broader environment where Progressive is situated?"
— Bob Huang, Morgan Stanley

A: "We don't know how long the soft market will prevail, but we have definitely seen a lot more competition because everyone has great margins... our focus will be to continue to grow as fast as we can at or below a 96... When we get more customers, we gather more data... it's a very nice flywheel that we've used for a long time."
— Tricia Griffith, CEO & President

Assessment: Management won't (and can't) call the cycle, but the flywheel framing is the right answer — Progressive's advantage compounds with scale and data regardless of the cycle phase. The honest acknowledgment that margins "can press, possibly" is appropriately candid and already in the stock.

Severity — Is the Benign Trend Durable?

A follow-up probed why collision severity has been so strong and whether it is sustainable as Progressive grows. Management characterized severity as ~3% with flat frequency, crediting claims management while flagging parts inflation and BI as the variables.

Q: "If we look at personal auto severity... aside from 2024, severity on collision hasn't been this good in 5 years. Can you help us get a better handle on severity trends, specifically collision — why is it so good, and is this durable as you're growing further?"
— Bob Huang, Morgan Stanley

A: "Severity has [run] about 3% overall. Frequency was flat... For PD and collision, we do see higher parts prices... we have some offsetting, cost of labor and things like that are not accelerating as fast... it's hard to say on collision going forward, but we feel good about the trends we're seeing today."
— Tricia Griffith / Andrew Quigg

Assessment: A benign, well-understood loss backdrop that supports sub-90 combined ratios and the room to cut price for growth. Management is appropriately non-committal on durability given parts/BI/macro variables, but nothing here threatens the margin profile.

Capital — Why a Special Dividend Over More Buyback?

A pointed question asked why Progressive chose a large special dividend over directing those funds to repurchases. Management walked through the discount-to-fair-value-scaled buyback framework and the residual nature of the dividend.

Q: "Are you willing to elaborate more on why Progressive chose a very large special dividend earlier this year versus directing more of those excess funds towards a buyback? ... share some of the math or thought that drove that allocation decision?"
— Mike Zaremski, BMO Capital Markets

A: "We look across [share repurchase, corporate development, investment risk]... we look to scale the share repurchase plan... based on how much of a discount we see the shares are trading versus our view of fair value... if after [those] decisions we still have excess capital... then we will look to return that as we did with our variable dividend."
— Jonathan Bauer, Chief Investment Officer

Assessment: The most useful exchange for our thesis. Management's buyback intensity is explicitly a function of the discount to fair value — so at ~10x earnings, its own framework should drive more repurchases. That is a self-reinforcing valuation support and a direct endorsement of the cheapness we see.

Premiums-to-Surplus — How High, How Fast?

An analyst pressed on whether Progressive is comfortable pushing toward the approved 3.5:1 leverage and what it means for GAAP ROE. Management confirmed the multi-year optimization runway and the ROE math.

Q: "Progressive has disclosed that the firm can get to a maximum 3.5 times premium to surplus on a statutory basis... how should we think about your criteria for premiums to surplus on a GAAP basis, and should we expect that to trend upwards?"
— Rob Cox, Goldman Sachs

A: "Our aspiration is to continue to move premium-to-surplus ratios up in those entities in which we have received approval... which obviously allows us to decrease the total equity we require on a GAAP basis, which obviously then can lead to higher ROEs."
— John Sauerland, CFO

Assessment: Confirms a multi-year, ROE-accretive structural tailwind that the market is not crediting — a direct, partial offset to the "ROE normalizes" bear case. The migration is incomplete, so the benefit extends through 2026–2027.

Premium-per-Policy and the Path of Pricing

An analyst asked about the drivers of declining written premium per policy and how it trends as less rate flows through the system. Management framed it as a deliberate, growth-oriented pricing posture.

Q: "Written premium per policy continued to go down in agency, kind of flat in direct... how would you expect the written premium per policy to trend from here?"
— Elyse Greenspan, Wells Fargo

A: "It'll be dependent on the pricing actions that we take in order to grow... right now it's been down about 1% in private passenger auto... our real measure of growth for long term is policies in force... we're going to go state by state, channel by channel to make sure that we're priced adequately in order to achieve our goal of growing as fast as we can."
— Tricia Griffith, CEO & President

Assessment: The negative premium-per-policy is a chosen growth lever, not pricing weakness — Progressive is trading a point of average premium for policy growth and affordability, consistent with its PIF-first philosophy. Healthy, not concerning.

Why Can Progressive Deploy So Much More Ad Spend Than Peers?

An analyst noted Progressive's accelerating media spend while peer ad budgets have flattened well below, asking what makes Progressive uniquely able to deploy it efficiently. Management pointed to its in-house media team and segmentation discipline.

Q: "Peer ad spend has somewhat flattened out at levels well below Progressive. What types of advertising is Progressive finding incrementally attractive... and why do you think Progressive is uniquely able to effectively deploy so much ad spend?"
— Rob Cox, Goldman Sachs

A: "One of the differentiators within our customer acquisition media is a really strong in-house media team where we buy virtually all of our media in-house... closely couples our media team with our product teams to understand at a more granular level the ultimate cost of a piece of media... we will continue to spend as long as it's efficient."
— Pat Callahan, President, Personal Lines

Assessment: The in-house, segmentation-driven media operation is a real and underappreciated edge — Progressive can profitably spend where peers cannot because it prices the lifetime profitability of each acquired risk. It is the same data-and-segmentation advantage that powers underwriting, applied to marketing. A durable competitive moat.

What They’re NOT Saying

1. No call on where industry margins or the soft market head: Management repeatedly declined to forecast the cycle or 2027 profitability, leaving the central bear question (how far does ROE normalize?) unanswered.
2. No quantified GenAI savings: "Meaningful, long-term" benefits and an internal ~10% productivity figure, but no committed expense-ratio target from AI.
3. No timeline to #1 US auto: Management is "closing in" but would not put a date on crossing the milestone.
4. No buyback magnitude or pace target: Tied qualitatively to the discount to fair value; no dollar or share commitment despite the cheap stock.
5. No sizing of the macro (fuel/Iran/tariff) loss-cost risk: Flagged as monitored, not quantified.
6. No 2026 Florida credit estimate: Beyond noting the Florida PLE lift from premium credits, no forecast for the year's policyholder-credit charge.

Market Reaction

Progressive's split cadence again separated the numbers from the call: Q1 2026 comprehensive results landed before the open on April 15, 2026; the investor call followed on May 5, 2026.

• Results-day (April 15): Up +2.4% to $201.23 from a $196.59 prior close (ranging $195.51–$203.12) on ~4.9M shares (~1.6x average) — a modest, constructive response to the revenue beat and steady combined ratio, shrugging off the immaterial EPS miss. The stock entered the print down ~13.7% YTD and ~28.8% over the trailing twelve months, near the low end of a $193.36–$288.74 52-week range.
• Call-day (May 5): Down −0.8% to $197.74 on roughly average volume — a non-event, as expected for a call whose numbers were three weeks old. The stock sat ~$197 entering our publication, hovering just above its 52-week low.

An honest accounting of our call. We upgraded to Outperform in November at ~$210. Through this print the stock is ~$197 — a ~6% price decline, or roughly a flat total return once the $13.50 January variable dividend is counted, but a clear lag versus a higher market. Every operating metric we underwrote has held or improved: the combined ratio is still mid-80s, PIF growth is still industry-leading, share keeps climbing toward #1, and management has been buying its own stock. What has gone against us is the multiple: the market has steadily compressed Progressive's earnings and book multiples as it discounts growth deceleration and ROE normalization. That repricing is the real risk, and it has been the painful surprise — but at ~10x earnings it is increasingly a feature of the entry, not a reason to abandon the thesis.

Street Perspective

Debate: Is ~10x Earnings a Bargain or a New, Lower Normal?

Bull view: A 35–40%-ROE franchise still gaining share, about to be #1 in US auto, running an 86.4 combined ratio with benign loss costs and a structural leverage/AI ROE tailwind, trading at ~10x earnings and ~3.6x book with management buying — this is a rare, mispriced quality compounder.

Bear view: The multiple is compressing because the 40% ROE was a cyclical peak that normalizes, growth has decelerated to high-single-digits, the soft market and competition persist, and there is no near-term catalyst — ~10x is the new fair value for a slower-growing, lower-ROE Progressive.

Our take: The ROE will normalize from 40%, but the leverage migration and expense leverage cushion the fall, and even a through-cycle low-20s comprehensive ROE supports a higher multiple than ~10x earnings. The market is discounting a worse outcome than the business is delivering. We side with the bull case — while conceding the bears have, so far, been right on the tape.

Debate: Does the Growth Deceleration Break the Thesis?

Bull view: Deceleration from +33% to ~+10% EPS growth is the inevitable lapping of records; Progressive still captured ~75–86% of all industry growth, is closing on #1, and has fresh legs in bundling, commercial, and GenAI-driven efficiency.

Bear view: The deceleration is the leading edge of a structural slowdown as the share-gain wave matures and competitors re-engage; high-single-digit growth is the new run-rate, not a trough.

Our take: Even if high-single-digit growth is the new normal, paired with a mid-80s combined ratio, a rising ROE from leverage, and aggressive capital return, that is more than enough to justify a re-rating from ~10x. The thesis doesn't require re-acceleration — just for the market to stop pricing decline.

Debate: Where Is the Catalyst?

Bull view: Crossing to #1 US auto, continued buybacks scaled to the discount, the leverage-migration ROE lift, and eventual recognition that loss trends are benign are all catalysts that compound over the next year.

Bear view: None of those are dated events; the stock can grind sideways-to-down for quarters while the multiple finds its floor, with no forcing function to close the gap.

Our take: The honest answer is that the catalyst is valuation plus time, not a single event — which is why the call has lagged. But management's own framework (buy more as the discount widens) and the structural ROE tailwind are the forcing functions we are underwriting. At ~10x, the wait is paid for by a cheap, compounding, capital-returning franchise.

Model Update Needed

Valuation framework: At ~$197, Progressive trades at ~10.0x trailing EPS (~$19.67 TTM) and ~3.6x book (~$54.86/share). For a franchise compounding high-single-digits with a mid-80s combined ratio, a 35–40% comprehensive ROE (with a structural leverage tailwind), and management buying its own shares scaled to the discount, ~10x earnings is a demonstrable discount to the quality. We see fair value in the ~$240–260 range (~12–13x normalized earnings on a growing book) and view the path as valuation-plus-time: continued buybacks, the #1-auto milestone, the leverage-migration ROE lift, and recognition of benign loss trends. The risk — which has dominated for two quarters — is further multiple compression if the market continues to re-rate the ROE lower faster than the business compounds. We judge that risk more than priced at 10x.

Thesis Scorecard Post-Earnings

Overall: Fundamentally unchanged-to-stronger; the franchise is executing and nearing #1 US auto. The thesis's weak point is not the business but the multiple, which has compressed faster than the business has grown — the bear's correct call for two quarters. We weigh the now-deep discount against that continued de-rating risk.

Action: Maintaining Outperform. We acknowledge plainly that the call has lagged since November — the cost has been multiple compression, not fundamentals. But at ~10x earnings and ~3.6x book for a share-gaining, mid-80s-combined-ratio, 35–40%-ROE franchise that is buying its own stock and nearing #1 in US auto, the risk/reward is, if anything, more favorable than at the upgrade. We stay Outperform, sized to the recognition that valuation-plus-time — not a dated catalyst — is the path, and that further de-rating is the risk we are underwriting against.